HomeSPH • WSE
add
Sopharma AD
Previous close
zł 13.75
Year range
zł 11.40 - zł 15.70
Avg Volume
98.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (BGN) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 543.31M | 17.45% |
Operating expense | 92.96M | 20.74% |
Net income | 18.59M | 30.21% |
Net profit margin | 3.42 | 10.68% |
Earnings per share | — | — |
EBITDA | 43.35M | 46.91% |
Effective tax rate | 9.90% | — |
Balance Sheet
Total assets
Total liabilities
| (BGN) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.10M | 118.65% |
Total assets | 1.58B | 9.47% |
Total liabilities | 734.14M | 3.66% |
Total equity | 841.72M | — |
Shares outstanding | 165.74M | — |
Price to book | 2.79 | — |
Return on assets | 3.37% | — |
Return on capital | 4.24% | — |
Cash Flow
Net change in cash
| (BGN) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 18.59M | 30.21% |
Cash from operations | 24.85M | 138.09% |
Cash from investing | 5.39M | 122.69% |
Cash from financing | -18.49M | -120.68% |
Net change in cash | 11.75M | 2,613.16% |
Free cash flow | -9.10M | 87.26% |
About
Founded
1933
Website
Employees
5,379
